Live daily coverage beginning June 1 from the ASCO meeting in Chicago.
The editorial teams in the Modern Medicine Primary Care Content Group, with content from our legacy brands - Medical Economics, Drug Topics, Geriatrics, Formulary and Contemporary OB/Gyn - will cover key medical meetings, bringing you breaking news, the latest research findings and reports from the general sessions.
Daily coverage from this year's American Society of Clinical Oncology (ASCO), begins now through June 3.
FDA Issues Complete Response Letter for Pz-Cel to Treat Epidermolysis Bullosa
April 22nd 2024Prademagene zamikeracel is a cell therapy designed to incorporate the functional collagen-producing COL7A1 gene into a patient’s own skin cells. The FDA is asking for additional information on manufacturing practices.